Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Thornton

Showing results (781-790 of 848) with videos related to

Pageof 85
Sort By:
Geophysical Research Letters|October 5, 2020
Anthropogenic control over wintertime oxidation of atmospheric pollutantsJ D Haskins, F D Lopez-Hilfiker, B H Lee, et al.
Nature Communications|June 16, 2026
Glycosylated extracellular matrix drives immune suppression by modulating macrophage-T cell crosstalk in triple-negative breast cancerLudovica Tarantola, Eleanor J Tyler, Ying Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Communications Medicine|January 18, 2025
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical modelsTimothy Weeden, Tyler Picariello, Brendan Quinn, et al.
Neurology|November 26, 2008
Subcutaneous IGF-1 is not beneficial in 2-year ALS trialE J Sorenson, A J Windbank, J N Mandrekar, et al.
The Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.
Plos Genetics|March 29, 2018
Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and diseaseLaura M Raffield, Jacob C Ulirsch, Rakhi P Naik, et al.
Nature|December 10, 2025
The influence of short-lived halogens on atmospheric chemistry and climateAlfonso Saiz-Lopez, Anoop S Mahajan, Jonathan Abbatt, et al.
Environmental Science & Technology|July 13, 2021
Variability and Time of Day Dependence of Ozone Photochemistry in Western Wildfire PlumesMichael A Robinson, Zachary C J Decker, Kelley C Barsanti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal TumorPing Chi, Li-Xuan Qin, Bastien Nguyen, et al.
Pageof 85

Showing results (781-790 of 848) with videos related to

Sort By:
Pageof 85
Geophysical Research Letters|October 5, 2020
Anthropogenic control over wintertime oxidation of atmospheric pollutantsJ D Haskins, F D Lopez-Hilfiker, B H Lee, et al.
Nature Communications|June 16, 2026
Glycosylated extracellular matrix drives immune suppression by modulating macrophage-T cell crosstalk in triple-negative breast cancerLudovica Tarantola, Eleanor J Tyler, Ying Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Communications Medicine|January 18, 2025
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical modelsTimothy Weeden, Tyler Picariello, Brendan Quinn, et al.
Neurology|November 26, 2008
Subcutaneous IGF-1 is not beneficial in 2-year ALS trialE J Sorenson, A J Windbank, J N Mandrekar, et al.
The Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.
Plos Genetics|March 29, 2018
Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and diseaseLaura M Raffield, Jacob C Ulirsch, Rakhi P Naik, et al.
Nature|December 10, 2025
The influence of short-lived halogens on atmospheric chemistry and climateAlfonso Saiz-Lopez, Anoop S Mahajan, Jonathan Abbatt, et al.
Environmental Science & Technology|July 13, 2021
Variability and Time of Day Dependence of Ozone Photochemistry in Western Wildfire PlumesMichael A Robinson, Zachary C J Decker, Kelley C Barsanti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal TumorPing Chi, Li-Xuan Qin, Bastien Nguyen, et al.
Pageof 85